[HTML][HTML] Targeting of promising transmembrane proteins for diagnosis and treatment of pancreatic ductal adenocarcinoma

V Mashayekhi, O Mocellin, MHAM Fens, GC Krijger… - Theranostics, 2021 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal types of cancer due to the
relatively late diagnosis and the limited therapeutic options. Current treatment regimens …

Subcellular expression of maspin in colorectal cancer: Friend or foe

S Gurzu, I Jung - Cancers, 2021 - mdpi.com
Simple Summary In this article we have highlighted the possible role of nuclear maspin in
identification of tumor cells “on the point of budding” and the epithelial mesenchymal …

[HTML][HTML] Solid pseudopapillary neoplasm of pancreas: Two case reports

S Gurzu, T Bara, M Sincu, S Gabos, DM Vlad, T Bara Jr… - Medicine, 2019 - journals.lww.com
Interventions: Surgical excision, in both cases. Outcomes: No recurrences in first case, at 5
months after diagnosis. Hepatic metastases in the second case, at 13 years after diagnosis …

Update on mucinous cystic neoplasm of the pancreas: a narrative review

W Xie, H Liang, Y Guo, SY Xiao - Journal of Pancreatology, 2021 - mednexus.org
Mucinous cystic neoplasm (MCN) of the pancreas is an exocrine cystic tumor with a potential
of harboring malignancy. The latest World Health Organization classification of tumors of …

[HTML][HTML] Markers of Epithelial–Mesenchymal Transition and Mucinous Histology Are Significant Predictors of Disease Severity and Tumor Characteristics in Early …

A Djikic Rom, S Dragicevic, R Jankovic… - Diagnostics, 2024 - mdpi.com
Approximately 20% of patients with colorectal cancer (CRC) are diagnosed with a mucinous
subtype of this tumor, have a worse prognosis, and often show resistance to available …

Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm …

J Chen, P Wang, K Lv, W Zhou - Diagnostic Pathology, 2021 - Springer
Background Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) of the
pancreas are extremely rare. Their pathogenesis and molecular landscape are largely …

[HTML][HTML] Subcellular expression of maspin–from normal tissue to tumor cells

L Banias, I Jung, S Gurzu - World Journal of Meta-Analysis, 2019 - wjgnet.com
Maspin or SerpinB5, a member of the serine protease inhibitor family, was shown to function
as a tumor suppressor, especially in carcinomas. It seems to inhibit invasion, tumor cells …

[PDF][PDF] Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice

J Gašperšič, A Videtič Paska - Biochemia Medica, 2020 - hrcak.srce.hr
Review Page 1 Abstract Personalized medicine is a developing field of medicine that has
gained in importance in recent decades. New diagnostic tests based on the analysis of …

A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional …

M Yang, L Zeng, WQ Yao, N Ke, C Tan, X Liu, B Xiang… - Medicine, 2020 - journals.lww.com
Abstract Histologically, the World Health Organization has classified pancreatic
neuroendocrine neoplasms (p-NENs) into well-differentiated pancreatic neuroendocrine …

[HTML][HTML] Development and external validation of a nomogram with inflammatory markers for predicting invasiveness of intraductal papillary mucinous neoplasm of …

SJ Yoon, H Kim, O Lee, JH Jung, CS Lim, YC Shin… - Medicine, 2022 - journals.lww.com
Recent studies have reported that inflammatory markers, such as neutrophil-to-lymphocyte
ratio, platelet-to-lymphocyte ratio, and advanced lung cancer inflammation index, are …